vascular parkinsonism

vascular parkinsonism
Name	Vascular parkinsonism
Synonyms	Arteriosclerotic parkinsonism, lower body parkinsonism
Symptoms	Gait disturbance, postural instability, cognitive impairment
Complications	Falls, dementia, urinary incontinence
Onset	Typically older age
Duration	Chronic
Causes	Cerebrovascular disease
Risks	Hypertension, diabetes, smoking
Diagnosis	Clinical, neuroimaging
Differential	Parkinson's disease, normal pressure hydrocephalus, progressive supranuclear palsy
Treatment	Vascular risk management, physical therapy
Medication	Levodopa (often less effective)
Prognosis	Variable, often progressive

vascular parkinsonism is a form of secondary parkinsonism resulting from cerebrovascular disease. It is characterized by parkinsonian symptoms, primarily gait and postural disturbances, attributed to ischemic lesions in the brain. The condition is distinct from the neurodegenerative process of Parkinson's disease and is often associated with a history of stroke or significant small vessel disease. Diagnosis relies on clinical assessment and neuroimaging evidence of vascular pathology.

Definition and classification

Vascular parkinsonism is classified as a secondary or symptomatic parkinsonian syndrome within the broader spectrum of movement disorders. It is formally recognized in diagnostic criteria, such as those proposed by the Movement Disorder Society, which emphasize the temporal relationship between cerebrovascular events and symptom onset. The condition is sometimes subdivided into types, such as acute post-stroke parkinsonism and the more insidious lower-body parkinsonism associated with diffuse white matter changes. This classification helps differentiate it from other akinetic-rigid syndromes like multiple system atrophy or corticobasal degeneration.

Signs and symptoms

The clinical presentation often features prominent lower-body involvement, leading to a broad-based, shuffling gait and severe postural instability, a pattern sometimes termed "lower body parkinsonism." Unlike Parkinson's disease, resting tremor is less common, while features like pyramidal tract signs, early cognitive decline, and urinary incontinence are more frequent. Patients may exhibit a magnetic gait, characterized by feet seeming stuck to the floor, and show limited response to dopaminergic medications. Additional signs can include pseudobulbar affect and evidence of previous transient ischemic attack.

Causes and pathophysiology

The primary cause is ischemic cerebrovascular disease affecting critical brain regions involved in motor control. Pathophysiologically, lesions in the basal ganglia, particularly the globus pallidus and putamen, or in the frontal subcortical white matter tracts disrupt the corticostriatothalamocortical circuit. These infarcts or diffuse leukoaraiosis impair dopaminergic and non-dopaminergic pathways, leading to akinesia and rigidity. Major risk factors mirror those for stroke and include hypertension, diabetes mellitus, hyperlipidemia, and a history of cardiovascular disease.

Diagnosis

Diagnosis is primarily clinical, based on the presence of parkinsonism and documented cerebrovascular disease. Neuroimaging, particularly magnetic resonance imaging of the brain, is crucial for revealing evidence of relevant vascular pathology, such as lacunar infarcts in the basal ganglia or extensive periventricular white matter hyperintensities. The diagnostic process often involves ruling out other conditions through DaTscan imaging, which typically shows preserved striatal dopamine transporter binding in vascular parkinsonism, unlike in Parkinson's disease. Criteria from institutions like the National Institute of Neurological Disorders and Stroke aid in standardization.

Treatment and management

Management focuses on controlling vascular risk factors through medications like antihypertensives and statins, and lifestyle modifications to prevent further cerebrovascular events. Physical therapy and gait training are cornerstone interventions to improve mobility and prevent falls. While a trial of levodopa is often conducted, the response is usually poor or absent. Other symptomatic treatments may include management of associated depression, bladder dysfunction, and spasticity. Surgical interventions such as deep brain stimulation are generally not effective for this condition.

Prognosis

The prognosis is variable but often involves a stepwise or gradually progressive decline in motor and cognitive functions. The course is less predictable than the relatively steady progression of Parkinson's disease and is heavily influenced by the prevention of subsequent strokes. Patients are at high risk for complications such as falls leading to hip fracture, severe dementia, and loss of independence. Life expectancy can be reduced, particularly with extensive cerebrovascular disease or recurrent major cardiovascular events.

Category:Parkinsonism Category:Cerebrovascular diseases